NVIDIA’s Clara healthcare platform uses AI to study COVID-19

By William Smith
Graphics card manufacturer NVIDIA has, in more recent times, branched out from mainly focusing on gaming to areas such as automotive and, increasingly...

Graphics card manufacturer NVIDIA has, in more recent times, branched out from mainly focusing on gaming to areas such as automotive and, increasingly, healthcare.

A number of companies participating in the company’s Inception startup accelerator programme have interests in healthcare. One, Deep 6 AI, focuses on using machine learning to analyse medical records and identify potential candidates for medical trials. Another, Aiforia, is using AI to automate the analysis of tissue samples.

Nvidia’s CEO Jensen Huang has expressed his belief in the role of AI to power a new era of computing, writing in a blog post: “Today, we stand at the beginning of the next era, the AI computing era, ignited by a new computing model, GPU deep learning. This new model — where deep neural networks are trained to recognize patterns from massive amounts of data — has proven to be “unreasonably” effective at solving some of the most complex problems in computer science. In this era, software writes itself and machines learn. Soon, hundreds of billions of devices will be infused with intelligence. AI will revolutionize every industry.”

SEE ALSO:

NVIDIA’s own Clara healthcare platform serves as a framework for AI-powered imaging, genomics, and for the development and deployment of smart sensors.

Amidst the ongoing COVID-19 pandemic, NVIDIA announced it was expanding the platform to assist the medical community “track, test and treat” COVID-19. Those expansions include genome sequencing software, AI models to help with disease detection and video analytics and speech recognition software to reduce staff exposure in hospitals.

“The COVID-19 pandemic has supercharged the collaboration of technology, research and the healthcare industry to develop new computing solutions that accelerate the understanding of the spread, scale and severity of this disease,” said Kimberly Powell, vice president of Healthcare at NVIDIA. “Never before has there been such a critical need to apply the best AI technology and accelerated computing to every facet of healthcare, and its effects will be felt widely beyond this pandemic and across healthcare going forward.”

(Image: NVIDIA)

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma